BioCentury | Oct 6, 2014
Company News

Lumara Health, AMAG Pharmaceuticals deal

...million. Perrigo will gain Lumara's Clindesse clindamycin phosphate and Gynazole-1 butoconazole nitrate vaginal creams and Evamist...
BioCentury | Oct 6, 2014
Company News

Lumara Health, Perrigo deal

...cash. Perrigo will gain Lumara's Clindesse clindamycin phosphate and Gynazole-1 butoconazole nitrate vaginal creams and Evamist...
...imidazole derivative with antifungal activity -- is marketed to treat vaginal Candida yeast infection; and Evamist...
BioCentury | Sep 30, 2014
Company News

AMAG gains on M&A deal to add Makena

...million, giving it rights to Clindesse clindamycin phosphate and Gynazole-1 butoconazole nitrate vaginal creams and Evamist...
BioCentury | Dec 17, 2012
Company News

Hologic, KV Pharmaceutical genitourinary news

...portfolio, including Makena, bacterial vaginosis drug Clindesse , vulvovaginal candidiasis drug Gynazole-1 and menopause drug Evamist...
BioCentury | Dec 5, 2011
Clinical News

EvaMist regulatory update

...FDA updated the label of EvaMist estradiol metered-dose transdermal spray to include a boxed warning that...
...gynecomastia have been reported in children following unintentional secondary exposure to the drug. Acrux licensed EvaMist...
...Ltd. (ASX:ACR), Melbourne, Australia Vivus Inc. (NASDAQ:VVUS), Mountain View, Calif. Product: EvaMist ( Ellavie ) estradiol MDTS...
BioCentury | Aug 9, 2010
Clinical News

EvaMist estradiol MDTS regulatory update

...FDA issued a warning about inadvertent exposure of EvaMist to children and animals through skin contact...
...in nipple enlargement and vulvar swelling. FDA plans to continue reviewing related reports. Acrux licensed EvaMist...
...Acrux Ltd. (ASX:ACR), Melbourne, Australia Vivus Inc. (NASDAQ:VVUS), Mountain View, Calif. Product: EvaMist estradiol MDTS ( Ellavie...
BioCentury | Apr 5, 2010
Company News

KV endocrine news

...KV reduced headcount by 289 (42%) to 391 to save cash. KV markets EvaMist estradiol transdermal...
BioCentury | Oct 5, 2009
Company News

Acrux, HRA Pharma sales and marketing update

...delivered via the Metered-Dose Transdermal Spray is marketed in the U.S. under the brand name EvaMist...
BioCentury | Aug 18, 2008
Company News

Acrux, KV Pharmaceutical deal

...use Acrux’s spray technology to include up to six new compounds. KV already markets Acrux’s EvaMist...
...and royalties. Acrux also will have rights to use data from KV’s regulatory submissions for Evamist...
...delivered via metered-dose transdermal spray, which it will market as Ellavie , in the EU. Evamist...
BioCentury | Aug 6, 2008
Top Story

Vivus raises $65 million

...U.S. rights to Evamist estradiol transdermal spray to KV (NYSE:KVA). Vivus received U.S. rights to Evamist...
Items per page:
1 - 10 of 45